HomeLEXX • NASDAQ
Lexaria Bioscience Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | 174.00K | 20.00% |
Operating expense | 2.93M | 259.78% |
Net income | -2.71M | -317.71% |
Net profit margin | -1.56K | -248.09% |
Earnings per share | — | — |
EBITDA | -2.75M | -321.54% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.54M | 36.51% |
Total assets | 8.68M | 36.61% |
Total liabilities | 1.92M | 838.67% |
Total equity | 6.76M | — |
Shares outstanding | 17.56M | — |
Price to book | 2.44 | — |
Return on assets | -74.47% | — |
Return on capital | -83.82% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | -2.71M | -317.71% |
Cash from operations | -1.50M | -141.75% |
Cash from investing | -27.89K | 51.05% |
Cash from financing | 11.72K | -99.66% |
Net change in cash | -1.61M | -158.49% |
Free cash flow | -687.91K | -52.03% |
Previous close
$1.00
Day range
$0.93 - $0.99
Year range
$0.92 - $4.38
Market cap
18.90M USD
Avg Volume
119.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2004
Website
Employees
7
